KELLEY SCOTT 4
4 · Flexion Therapeutics Inc · Filed Feb 2, 2018
Insider Transaction Report
Form 4
KELLEY SCOTT
Chief Medical Officer
Transactions
- Award
Common Stock
2018-02-01+8,333→ 14,892 total - Award
Stock option (right to buy)
2018-02-01+33,333→ 33,333 totalExercise: $22.31Exp: 2028-01-31→ Common Stock (33,333 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest one year after January 1, 2018; thereafter one-forty-eighth (1/48th) of the shares subject to the option shall vest each month following the one year anniversary of January 1, 2018, so that all of the shares subject to the option shall be vested four (4) years after January 1, 2018.